AUSPIRE_POSTDOCTORAL FELLOWSHIP_PSYCHOSOCIAL DETERMINANTS OF ADHERENCE TO DIGITAL THERAPEUTICS

Position code.
IGTP-PF1 Research line.
Psychosocial Determinants of Adherence to Digital Therapeutics Employing entity Germans Trias i Pujol Research Institute (IGTP)  Seconding.
RMIT University  Position funded by COFUND, Marie Sklodowska-Curie Actions (MSCA), Horizon Europe, European Union, Germans Trias i Pujol Research Institute (IGTP), RMIT University (RMIT) Supervisors.
Meritxell Davins Riu (IGTP), Vasileios Stavropoulos (RMIT), Gabriela Irrazabal (RMIT)  Foreseen start date.
September   Gross annual salary EUR, plus complements defined below This research line focuses on the psychosocial determinants affecting patient adherence to prescribed digital therapeutics, particularly telemedicine interventions across various health conditions.
Adopting a mixed-methods approach, including indepth qualitative methods such as interviews, focus groups, and thematic analysis, the research line explores the barriers and facilitators to telemedicine adherence among patients with high digital literacy levels.
The aim of the research line is to generate actionable knowledge to inform the development of strategies and interventions to enhance patient engagement and improve adherence to prescribed telemedicine therapies, ultimately contributing to the effectiveness of digital health interventions.
The proposed project will leverage a comprehensive dataset containing patient records from over 40 health conditions, enabling robust quantitative analyses alongside with qualitative insights.
The integration of these methods will provide a holistic understanding of adherence behaviour, identifying key barriers and enablers, offering an evidence-based foundation for exploring strategies to improve adherence rates.
These findings will also inform the design and piloting of targeted interventions to enhance the effectiveness of digital therapeutics in real-world settings.
By addressing challenges in digital therapeutics adherence, this research contributes to regenerative futures and planetary health by advancing the adoption of restorative healthcare practices.
Improved adherence to digital therapeutics enhances individual wellbeing while reducing the environmental footprint associated with traditional in-person care, such as travel and use of resources.
Furthermore, optimising digital therapeutics adherence can decrease healthcare system costs while fostering a more resilient and adaptive approach to health interventions that benefits both individuals and the broader ecosystem.
QUALIFICATIONS AND EXPERIENCIE Academic background.
A PhD.
in psychology, social psychology, medical/health sociology, or a related field with a strong focus on healthcare attitudes and behaviours.
Research expertise.
Experience in mixed methods, with strong skills in both qualitative (interviews, focus groups, hospital ethnography, content and thematic analysis) and quantitative methods (statistical modeling, dataset analysis).
Relevant knowledge.
Familiarity with digital therapeutics, digital health interventions, digital health literacy.
Skills.
Strong methodological design capabilities, including developing and evaluating interventions.
Advance knowledge of data analysis tools.
Excellent written and verbal communication skills for disseminating research findings effectively.
Languages.
A strong command of English is required for academic writing, presentations, and collaboration in an international research environment.
Intermediate Spanish and/or Catalan is high desirable as these are the primary languages of communication within the local working environment, patients and research stakeholders.
Please note that candidates must not have lived in Spain for more than 12 months in the past three years (since April ) and must have been awarded a PhD.
This is according to the European Commission's rule, with exceptions only for refugees and national service requirements.
WHAT WE OFFER Germans Trias i Pujol Research Institute offers a 36-month (3-year) postdoctoral full employment contract to work at its facilities in Badalona, Spain as part of the AuSpire researcher training program, co-funded by the European Commission under the MSCA COFUND scheme.
The total working hours per week are 38 and there is a probation period of 6 months.
The remuneration, in line with the European Commission rules for Marie SkłodowskaCurie grant holders, will consist of a gross annual salary of EUR.
The definite amount to be received by the Postdoctoral Fellow is subject to Spanish tax legislation.
The position will be jointly supervised by Germans Trias i Pujol Research Institute (Employing Entity) and RMIT (Seconding Entity), where the Postdoctoral Fellow must undertake a secondment at the headquarters of the latter in Melbourne, Australia for up to 12 months.
Additionally, the program includes annual in-person workshops at various locations across Spain, along with online training and networking activities Benefits include.
EUR relocation for employment stipend to cover costs associated to taking up employment (flights, visa, insurance, etc.), to be distributed monthly as a top-up to the gross salary.
EUR relocation for secondment stipend to cover compulsory project-related travel and accommodation costs (flights, visa, insurance, accommodation, etc.).
EUR travel stipend to cover flights and accommodation for participating in compulsory AuSpire training and networking events in Spain over the 3 years.
314 EUR monthly family allowance offered to candidates who meet the criteria.
Access to all the necessary facilities and laboratories at IGTP and RMIT.
Access to research and training facilities.
Telemedicine program with more than 80 user cases and patients enrolled.
23 days of paid holiday leave and 5 personal days + 2 days for Easter + 2 days for Christmas.
Flexible payment (childminding vouchers).
Becoming a Marie Sklodowska-Curie fellow and be invited to join the Marie Curie Alumni Association